|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$6.82 |
$7.24 |
$6.74 |
$7.12 |
173.20K | 04/23/2024 |
$7.22 |
$7.55 |
$7.02 |
$7.26 |
208.30K | 04/24/2024 |
$7.28 |
$7.51 |
$7.11 |
$7.38 |
90.70K | 04/25/2024 |
$7.26 |
$7.46 |
$7.04 |
$7.29 |
107.40K | 04/26/2024 |
$7.34 |
$7.46 |
$7.12 |
$7.32 |
92.10K |
|
TScan Therapeutics is a clinical-stage biopharmaceutical company focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. Co.'s proprietary platform is designed to: discover anti-cancer TCRs from patients with exceptional responses to immunotherapy; discover TCRs that recognize clinically validated targets; identify off-targets of TCRs to eliminate candidates; and manufacture TCR-T therapies using Co.'s T-Integrate technology. The central elements of Co.'s platform that differentiate it from other cell therapy companies are TargetScan, ReceptorScan, SafetyScan, ImmunoBank and T-Integrate. | |
|
TScan Therapeutics (TCRX) has the following price history information. Looking back at TCRX historical stock prices for the last five trading days, on April 22, 2024, TCRX opened at $6.82, traded as high as $7.24 and as low as $6.74, and closed at $7.12. Trading volume was a total of 173.20K shares. On April 23, 2024, TCRX opened at $7.22, traded as high as $7.55 and as low as $7.02, and closed at $7.26. Trading volume was a total of 208.30K shares. On April 24, 2024, TCRX opened at $7.28, traded as high as $7.51 and as low as $7.11, and closed at $7.38. Trading volume was a total of 90.70K shares. On April 25, 2024, TCRX opened at $7.26, traded as high as $7.46 and as low as $7.04, and closed at $7.29. Trading volume was a total of 107.40K shares. On April 26, 2024, TCRX opened at $7.34, traded as high as $7.46 and as low as $7.12, and closed at $7.32. Trading volume was a total of 92.10K shares.
TCRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into TScan Therapeutics shares, starting with a $10,000 purchase of TCRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/19/2021 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$10.01 |
|
End price/share: |
$7.32 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-26.87% |
|
Average Annual Total Return: |
-10.67% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,313.67 |
|
Years: |
2.77 |
|
|
|
Date |
Close |
04/22/2024 | $7.12 | 04/23/2024 | $7.26 | 04/24/2024 | $7.38 | 04/25/2024 | $7.29 | 04/26/2024 | $7.32 |
|
|